Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials

BACKGROUND: Multiple sclerosis (MS) is a chronic illness involving the central nervous system (CNS) that is characterised by inflammation, demyelination, and degenerative changes. Dalfampridine is one of the available treatments for MS symptoms and comorbidities. This meta-analysis aimed to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Enyao, Tian, Xin, Li, Ruoming, Chen, Chaoyang, Li, Min, Ma, Lingyun, Wei, Ran, Zhou, Ying, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885571/
https://www.ncbi.nlm.nih.gov/pubmed/33588903
http://dx.doi.org/10.1186/s13023-021-01694-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885571/
https://www.ncbi.nlm.nih.gov/pubmed/33588903
http://dx.doi.org/10.1186/s13023-021-01694-8

Ejemplares similares